Japanese Biotech Stock News

Meiji Holdings (TSE:2269) has laid out its latest scorecard for Q3 2026, with recent quarterly figures showing revenue in the ¥270.0 billion to ¥306.0 billion range and EPS between roughly ¥26.5 and ¥62.0 across the last six reported quarters, giving investors a clear view of how the top and bottom line have been tracking. Over that stretch, the company has seen revenue move from ¥278.7 billion in Q1 2025 to ¥301.3 billion in Q2 2026, while quarterly EPS shifted from ¥50.22 to ¥41.99. This...

Osaka Soda Co., Ltd. reported past nine-month results to December 31, 2025, with sales of ¥73,688 million versus ¥74,650 million a year earlier, while net income rose to ¥10,640 million and basic earnings per share from continuing operations increased to ¥84.92 from ¥62.59. Over the same period, Osaka Soda also completed a buyback of 2,484,500 shares for ¥4,999.91 million, reducing its share count while lifting earnings per share despite slightly lower sales. We will now examine how Osaka...

Lasertec Corporation reported half-year results to December 31, 2025, with sales of ¥128,258 million and net income of ¥45,745 million, alongside announcing a second-quarter dividend increase to ¥132.00 per share from ¥115.00 a year earlier, payable on March 12, 2026. The company also raised its full-year fiscal 2026 guidance, citing earlier customer acceptance of products and a revised yen/US$ exchange rate assumption of ¥145 per US$ compared with ¥135 previously. We will examine how...

What the latest earnings, guidance and dividend signal for investors FUJIFILM Holdings (TSE:4901) has given investors a fresh information set, combining third quarter and nine month earnings, new full year guidance for fiscal 2026, and an affirmed year end dividend outlook. The company reported third quarter sales of ¥857,354 million and net income of ¥73,143 million, alongside nine month sales of ¥2,429,717 million and net income of ¥193,375 million, each higher than the comparable period a...

Mitsubishi Estate Co., Ltd. recently approved a share repurchase program of up to 13,000,000 shares for ¥30,000 million and raised its earnings guidance for the year ending March 31, 2026, while also announcing several board resignations and a planned change in its Representative Corporate Executive Officer effective April 1, 2026. Together with a ¥29 billion subordinated bond issuance, these moves highlight how Mitsubishi Estate is reshaping its balance sheet and governance to support its...

Oki Electric Industry Co., Ltd. ( TSE:6703 ) will increase its dividend from last year's comparable payment on the 26th...

The board of Toho Gas Co., Ltd. ( TSE:9533 ) has announced that it will pay a dividend of ¥45.00 per share on the 26th...

Stanley Electric Co., Ltd. ( TSE:6923 ) has announced that it will be increasing its dividend from last year's...

Why the Myrbetriq legal settlement matters for Astellas shareholders Astellas Pharma (TSE:4503) has just closed its U.S. patent disputes over overactive bladder drug Myrbetriq, securing settlement and upfront licensing payments from Lupin and Zydus, as well as ongoing per unit fees. For you as an investor, this combination of cash inflows and reduced legal uncertainty can influence how you view the earnings profile tied to Myrbetriq and its generic competition in the U.S. market. See our...

The board of Wakachiku Construction Co., Ltd. ( TSE:1888 ) has announced that it will be paying its dividend of ¥131.00...

The board of Alleanza Holdings Co., Ltd. ( TSE:3546 ) has announced that it will pay a dividend of ¥19.00 per share on...

The board of Kohnan Shoji Co., Ltd. ( TSE:7516 ) has announced that it will pay a dividend on the 1st of June, with...

JMDC Inc. reported earnings for the nine months ended December 31, 2025, with sales of ¥36,488 million and net income of ¥4,811 million, both higher than the prior-year period. The improvement in both basic and diluted earnings per share from continuing operations points to more efficient profit generation over the period. We will now examine how JMDC’s stronger earnings per share performance could influence the company’s broader investment narrative. The latest GPUs need a type of rare...

Investor attention has turned to Toho Bank (TSE:8346) after the lender reported sharply higher nine month profits, raised its full year earnings guidance, and lifted dividend projections despite slightly softer capital adequacy ratios. See our latest analysis for Toho Bank. The upgraded guidance and higher dividend outlook have gone hand in hand with strong momentum, with a 31.33% 1 month share price return and a 155.89% 1 year total shareholder return suggesting investor enthusiasm has been...

K's Holdings (TSE:8282) just released earnings for the nine months to December 31, 2025, reporting sales of ¥564,400 million and net income of ¥13,726 million, along with higher basic and diluted earnings per share. See our latest analysis for K's Holdings. The latest earnings update comes on the back of steady share price momentum, with a 30 day share price return of 3.79% and a 1 year total shareholder return of 23.01%. This suggests sentiment has been improving over both shorter and longer...

It's been a good week for Marui Group Co., Ltd. ( TSE:8252 ) shareholders, because the company has just released its...

Tosoh Corporation's ( TSE:4042 ) investors are due to receive a payment of ¥50.00 per share on 5th of June. This makes...

Investors in TOC Co., Ltd. ( TSE:8841 ) had a good week, as its shares rose 2.5% to close at JP¥867 following the...

The subdued market reaction suggests that Toyota Motor Corporation's ( TSE:7203 ) recent earnings didn't contain any...

Earnings update and why it matters Blue Zones HoldingsLtd (TSE:417A) has put fresh numbers on the table, with nine month sales of ¥608,266 million, net income of ¥24,967 million, and basic earnings per share of ¥613.19 from continuing operations. See our latest analysis for Blue Zones HoldingsLtd. The earnings update has arrived alongside a steady share price trend, with a 9.84% 1 month share price return and an 11.36% year to date share price return. This sits alongside a 44.53% 3 year total...

Earnings and governance changes put Tokyu Construction in focus Tokyu Construction (TSE:1720) has drawn fresh attention after reporting nine month revenue of ¥239,560 million and net income of ¥7,969 million, alongside a board meeting considering leadership changes and a shift to an Audit and Supervisory Committee structure. See our latest analysis for Tokyu Construction. The earnings and governance announcements sit alongside strong recent market performance, with a 7 day share price return...

Sanrio Company (TSE:8136) has put investors on alert after a February 12 board meeting combined three shareholder focused moves: an upcoming stock split, higher full year earnings guidance, and an increased dividend forecast. See our latest analysis for Sanrio Company. Despite Sanrio’s stronger guidance and dividend outlook, the share price is currently ¥4,764, with a 3 month share price return of an 18% decline and a 1 year total shareholder return of a 22% decline, while the 5 year total...

Sekisui Chemical has now completed its previously announced share repurchase plan, buying back 10,000,000 shares (2.43% of shares) for ¥26,420.48 million by February 9, 2026. This completed buyback reduces the share count and may enhance per-share metrics, underlining management’s willingness to return capital to investors. Next, we’ll examine how the completion of this sizeable buyback program may influence Sekisui Chemical’s existing investment narrative. We've uncovered the 14 dividend...

Takeda Pharmaceutical (TSE:4502) just cleared two meaningful milestones, with the U.S. FDA granting Priority Review for its narcolepsy type 1 candidate oveporexton and a new AI-focused drug discovery collaboration with Iambic. See our latest analysis for Takeda Pharmaceutical. The recent regulatory progress for oveporexton and the AI drug discovery partnership with Iambic come as Takeda’s shares trade at ¥5,609, with a 30-day share price return of 11.73%, a 90-day share price return of...